
Discovery of the selective sphingomyelin synthase 2 inhibitors with the novel structure of oxazolopyridine
Keywords: ضد آترواسکلروز; SMS; sphingomyelin synthase; SM; sphingomyelin; PC; phosphatidylcholine; CHD; coronary heart disease; SMase; sphingomyelinase; SPT; serine palmitoyl transferase; AS; atherosclerosis; SMSr; SMS related protein; SAR; structure-activity relationships; IC50;